• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Fermenta Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
506414
INE225B01021
143.7924911
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
FERMENTA
20.44
1211.53
EPS(TTM)
Face Value()
Div & Yield %
20.14
5
0.89
 

CDSL records PAT of Rs 79.8 crore in Q4 FY26
May 02,2026

Total expenses for the period under review were Rs 163.95 crore, up 26.7% YoY.

The company posted a pre-tax profit of Rs 103.22 crore in Q4 FY26, down by 18.9% from Rs 127.20 crore in Q4 FY25.

For FY26, the bank has posted net profit and total income of Rs 455.08 crore (down 13.5% YoY) and Rs 1,144.92 crore (up 5.8% YoY), respectively.

Central Depository Services (India) (CDSL) enables the electronic holding, settlement, and transfer of securities, serving a wide range of market participants including depository participants, issuers, investors, RTAs, clearing corporations, and exchanges.

The scrip had declined 2.50% to end at Rs 1,273.80 on the NSE on Friday.